EWA
INBX icon

EverSource Wealth Advisors’s Inhibrx INBX Stock Holding History

EverSource Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95 Sell
1
-257
-100% -$25.8K ﹤0.01% 4312
2026
Q1 		$17.3K Buy
258
+96
+59% +$7.12K ﹤0.01% 2592
2025
Q4 		$12.8K Buy
162
+122
+305% +$8.31K ﹤0.01% 2676
2025
Q3 		$1.35K Buy
40
+18
+82% +$443 ﹤0.01% 3659
2025
Q2 		$314 Buy
22
+16
+267% +$207 ﹤0.01% 3989
2025
Q1 		$84 Hold
6
– – ﹤0.01% 3850
2024
Q4 		$92 Hold
6
– – ﹤0.01% 3563
2024
Q3 		$94 Hold
6
– – ﹤0.01% 2982
2024
Q2 		$87 Buy
+6
New +$94 ﹤0.01% 2999

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EverSource Wealth Advisors's INBX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Inhibrx (INBX) stake by 100% in Q2 2026, selling an estimated $25.8K and leaving 1 share worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #4312.

EverSource Wealth Advisors first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.3K in Q1 2026. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • EverSource Wealth Advisors held 1 share of Inhibrx worth $95 as of Q2 2026.
  • EverSource Wealth Advisors sold 257 Inhibrx shares in Q2 2026, an estimated $25.8K.
  • Inhibrx made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #4312 holding.
  • EverSource Wealth Advisors first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's Inhibrx position peaked at $17.3K in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.